Scholarly Index
Geraldine Ferron‐Brady
GlaxoSmithKline (United States); 1,144 total citations; 50 total publications; best world rank #621
GlaxoSmithKline (United States)
1,144Total citations
50Total publications
16H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Multiple Myeloma Research and Treatments | 2021-2025 | 621 | US 289 | 91.93 |
| Protein Degradation and Inhibitors | 2021-2025 | 734 | US 306 | 87.14 |